219 related articles for article (PubMed ID: 20615442)
1. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
Cass WA; Peters LE
Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442
[TBL] [Abstract][Full Text] [Related]
2. Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNF.
Cass WA; Peters LE
Neurochem Res; 2010 May; 35(5):727-34. PubMed ID: 20119638
[TBL] [Abstract][Full Text] [Related]
3. GDNF protection against 6-OHDA-induced reductions in potassium-evoked overflow of striatal dopamine.
Cass WA; Manning MW
J Neurosci; 1999 Feb; 19(4):1416-23. PubMed ID: 9952418
[TBL] [Abstract][Full Text] [Related]
4. Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle.
Rosenblad C; Kirik D; Devaux B; Moffat B; Phillips HS; Björklund A
Eur J Neurosci; 1999 May; 11(5):1554-66. PubMed ID: 10215908
[TBL] [Abstract][Full Text] [Related]
5. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
[TBL] [Abstract][Full Text] [Related]
6. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of GDNF against 6-OHDA in young and aged rats.
Fox CM; Gash DM; Smoot MK; Cass WA
Brain Res; 2001 Mar; 896(1-2):56-63. PubMed ID: 11277973
[TBL] [Abstract][Full Text] [Related]
8. Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor.
Kirik D; Rosenblad C; Björklund A
Eur J Neurosci; 2000 Nov; 12(11):3871-82. PubMed ID: 11069582
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
Oiwa Y; Yoshimura R; Nakai K; Itakura T
Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
[TBL] [Abstract][Full Text] [Related]
10. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons.
Horger BA; Nishimura MC; Armanini MP; Wang LC; Poulsen KT; Rosenblad C; Kirik D; Moffat B; Simmons L; Johnson E; Milbrandt J; Rosenthal A; Bjorklund A; Vandlen RA; Hynes MA; Phillips HS
J Neurosci; 1998 Jul; 18(13):4929-37. PubMed ID: 9634558
[TBL] [Abstract][Full Text] [Related]
11. Restorative effects of GDNF on striatal dopamine release in rats treated with neurotoxic doses of methamphetamine.
Cass WA; Manning MW; Bailey SL
Ann N Y Acad Sci; 2000 Sep; 914():127-36. PubMed ID: 11085315
[TBL] [Abstract][Full Text] [Related]
12. Differential in vivo effects of neurturin and glial cell-line-derived neurotrophic factor.
Hoane MR; Gulwadi AG; Morrison S; Hovanesian G; Lindner MD; Tao W
Exp Neurol; 1999 Nov; 160(1):235-43. PubMed ID: 10630208
[TBL] [Abstract][Full Text] [Related]
13. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF.
Hoffman AF; van Horne CG; Eken S; Hoffer BJ; Gerhardt GA
Exp Neurol; 1997 Sep; 147(1):130-41. PubMed ID: 9294410
[TBL] [Abstract][Full Text] [Related]
14. Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo.
Sullivan AM; Opacka-Juffry J; Blunt SB
Eur J Neurosci; 1998 Jan; 10(1):57-63. PubMed ID: 9753113
[TBL] [Abstract][Full Text] [Related]
15. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
Opacka-Juffry J; Ashworth S; Hume SP; Martin D; Brooks DJ; Blunt SB
Neuroreport; 1995 Dec; 7(1):348-52. PubMed ID: 8742486
[TBL] [Abstract][Full Text] [Related]
16. Augmented methamphetamine-induced overflow of striatal dopamine 1 day after GDNF administration.
Cass WA; Walker DJ; Manning MW
Brain Res; 1999 May; 827(1-2):104-12. PubMed ID: 10320698
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.
Cass WA; Peters LE; Fletcher AM; Yurek DM
Neurochem Res; 2014 Aug; 39(8):1467-76. PubMed ID: 24858239
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons.
Akerud P; Alberch J; Eketjäll S; Wagner J; Arenas E
J Neurochem; 1999 Jul; 73(1):70-8. PubMed ID: 10386956
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
20. Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.
Fjord-Larsen L; Johansen JL; Kusk P; Tornøe J; Grønborg M; Rosenblad C; Wahlberg LU
Exp Neurol; 2005 Sep; 195(1):49-60. PubMed ID: 15919076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]